Carlos A Zarate, M.D.
National Institute of Mental Health (NIMH) · Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carlos A Zarate, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:47 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06511908 · Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionNational Institute of Mental Health (NIMH) · recruiting · Suicide, Depressive Disorder, Treatment-Resistant, Ketamine · principal investigator
- Ph2NCT04821271 · Antidepressant Effects of TS-161 in Treatment-Resistant DepressionNational Institute of Mental Health (NIMH) · terminated · Major Depressive Disorder, Treatment-Resistant Depression, Depression · principal investigator
- Ph1NCT03973268 · Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major DepressionNational Institute of Mental Health (NIMH) · recruiting · Depression, Major Depressive Disorder, Major Depression · principal investigator
- N/ANCT03351764 · Development of Non-Invasive Brain Stimulation TechniquesNational Institute of Mental Health (NIMH) · completed · Normal Physiology · principal investigator
- N/ANCT03304665 · Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural StudiesNational Institute of Mental Health (NIMH) · recruiting · Healthy Volunteer · principal investigator
- N/ANCT03289923 · Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive EpisodesNational Institute of Mental Health (NIMH) · completed · Major Depressive Disorder · principal investigator
- Ph1NCT03065335 · Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive DisorderNational Institute of Mental Health (NIMH) · recruiting · Healthy Volunteer, Major Depressive Disorder, Depression · principal investigator
- Ph2NCT02543983 · Neurobiology of SuicideNational Institute of Mental Health (NIMH) · recruiting · Healthy Volunteers, Depression · principal investigator
- Ph2NCT02484456 · Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive DisorderNational Institute of Mental Health (NIMH) · completed · Major Depression · principal investigator
- N/ANCT02363296 · Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)National Institute of Mental Health (NIMH) · completed · Healthy Volunteers · principal investigator
- Ph1/Ph2NCT02049385 · Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?National Institute of Mental Health (NIMH) · terminated · Depression · principal investigator
- N/ANCT01313403 · Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive DisorderNational Institute of Mental Health (NIMH) · withdrawn · Major Depression, Unipolar Depression, Depression · principal investigator
- N/ANCT00697268 · p11 Protein Levels in Patients With Major Depressive Disorder Treated With CitalopramNational Institute of Mental Health (NIMH) · completed · Depression · principal investigator
- N/ANCT00024635 · Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersNational Institute of Mental Health (NIMH) · recruiting · Mood Disorders, Anxiety Disorders, Healthy Volunteers · principal investigator
- Ph1/Ph2NCT00088699 · Rapid Antidepressant Effects of Ketamine in Major DepressionNational Institute of Mental Health (NIMH) · completed · Depression, Mood Disorders, Major Depresssion · principal investigator
- Ph2NCT00086307 · Lexapro and Pramipexole and to Treat Major DepressionNational Institute of Mental Health (NIMH) · completed · Major Depression · principal investigator
- Ph2NCT00078715 · Rapid Antidepressant Effects of Yohimbine in Major DepressionNational Institute of Mental Health (NIMH) · completed · Depression, Involutional, Major Depresssion · principal investigator
- Ph2NCT00055575 · Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesNational Institute of Mental Health (NIMH) · terminated · Mood Disorders, Healthy, Unipolar Depression · principal investigator
- Ph2NCT00054704 · Riluzole to Treat Depression in Bipolar DisorderNational Institute of Mental Health (NIMH) · terminated · Bipolar Disorder · principal investigator
- N/ANCT00001246 · Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy VolunteersNational Institute of Mental Health (NIMH) · completed · Attention Deficit Hyperactivity Disorder, Schizophrenia, Attention Deficit Disorder With Hyperactivity · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.